Loading this company
Molina Healthcare, Inc.
MOHPrices in USD
TickerWorth ScoreC49/100
What we think
Priced above our range of $197.34 to $201.91.A range by design: peer multiples and our researched mid-cycle DCF.
Price
$207.26USD down −$0.10 (−0.05%)
Quoted · Prices are delayed.
Showing the last price we hold for this listing, recorded 2026-10-19 15:42 UTC (4 hours ago).
Why did it move today?
Nothing we can cite explains today’s move for this company.
Is it cheap?
Our range from 2 models, on today’s numbers
$197.34–$201.91
A range by design: peer multiples and our researched mid-cycle DCF.
Led by peer multiples (P/E, EV/EBITDA, P/S) · Cyclical business
Price $207.26Priced · Prices are delayed.
Is it a good business?
- Valuation100 out of 100
- Growth0 out of 100
- Financial health100 out of 100
- Past performance17 out of 100
Bull, base, bear
Our forward range over 12 months is part of Pro. See plans
The street
Analysts’ mean target
$209.12 across 17 analysts
The high and low of the analyst range is part of Pro. See plans
What does it do?
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates in the Healthcare Plans industry (Healthcare sector), headquartered in United States. The company employs roughly 19,000 people.
Key stats
52-week range$121.06–$244.89
- Open
- $207.37
- Day high
- $212.62
- Day low
- $207.26
- Previous close
- $207.36
- Volume
- 117,060 · 0.13× avg
- Average volume
- 889,381
- Market cap
- $10,818,971,648.00
- P/E (TTM)
- 2,302.89
- Earnings per share
- $0.09
- Beta
- 0.78
Prices are delayed. The feed does not say when these figures were taken.
What’s the latest?
- Reported quarterly or annual results
- Issued a public disclosure (Reg FD)
- Changed leadership or its board
- Issued a public disclosure (Reg FD)
- Reported quarterly or annual results
- Issued a public disclosure (Reg FD)
- Signed a material agreement
Top news
No recent headlines we can cite for this company.
Insider trades
The 90-day buying-and-selling read is part of Pro. See plans
- ZORETIC RICHARD CGrant / award · $54,978.40
- WOLF DALE BGrant / award ·
Not investment advice. TickerWorth Score is a model output.